Gene-Disorder Association · Article
Gene
MAP2K1Mitogen-Activated Protein Kinase Kinase 1
×
First reported
2003
Supporting publications
7
Manually curatedApproved treatment annotated
Association Review
In brief
The association between MAP2K1 (Mitogen-Activated Protein Kinase Kinase 1) and Melanoma is reported, with clinical genetic testing available.
Sources
1
Clinical variants
0
Symptoms
2
Compounds
6
Trials
237of 648 via MAP2K1 compounds
Publications
7
01
At a glance
Association overview
A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.
Request access
02
Provenance
Evidence and sources
1 source
Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.
Request access
2 source summaries
A gene summary alongside the source descriptions it was distilled from.
Request access
7 database identifiers
The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).
Request access
05
Mechanism overlap
Shared mechanisms
1 shared pathway
Biological pathways and phenotype concepts shared by the gene and the disorder, with supporting publications.
Request access
06
Interventions
Therapeutics
6 compounds & drugs
Gene-targeting drugs and associated compounds, with class, approval status, mechanism, indications and trials.
Request access
07
Human studies
Clinical trials
648 clinical trials
Clinical trials reached through the pair’s compounds, keeping disorder-targeting trials separate from other indications.
Request access
7 publications
Publications linking the gene and the disorder, with title, authors, journal, year and citation metrics.
Request access
09
Provenance
References & sources
20 references
Every source and publication cited across this dossier, as one numbered reference list.
Request access